AbbVie Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) dropped 0.70% to $148.55 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.19% to 4,019.81 and the Dow Jones Industrial Average rising 0.76% to 33,629.56. AbbVie Inc. closed $27.36 below its 52-week high ($175.91), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.25% to $168.31 and Pfizer Inc. (PFE) fell 0.29% to $44.98. Trading volume (7.6 M) eclipsed its 50-day average volume of 5.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 23, 2023.
(END) Dow Jones Newswires
January 23, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.